Stap-coc ClfA

CF-102 agonist : Treatment modification after initiating second-line medication for type 2 diabetes

T0901317 : Anti-inflammatory effects of naturally occurring retinoid X receptor agonists isolated from Sophora tonkinensis Gagnep. via retinoid X receptor/liver X receptor heterodimers

Lomitapide : Multimodal Treatment of Homozygous Familial Hypercholesterolemia

1400W : Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes

Vevorisertib : Phase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN-mutated advanced solid tumors

Cy7 DiC18: The influence of the image registration method on the adaptive radiotherapy. A proof of the principle in a selected case of prostate IMRT

Galunisertib: Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor b Superfamily Type 1 Receptors

CCT245737 : Pharmacoinformatics-based prediction of Checkpoint kinase-1 inhibitors from Momordica charantia Linn. for cancer

NVP-TAE684: Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L